News & Updates

Pandemic exposure tied to delayed childhood development

Children exposed to the pandemic are likely to exhibit a development delay at age 5 years, according to a study.

ADPKD: Halting kidney function decline

Autosomal dominant polycystic kidney disease (ADPKD) is one of the leading causes of kidney failure. In an interview with MIMS, Professor Sydney Tang of Department of Medicine, The University of Hong Kong, discussed ADPKD diagnosis and management, particularly in patients at high risk of rapid progression.

 Watch this video to find out how to identify ADPKD rapid progressors and how to delay renal function deterioration in these at-risk patients. 

Mirvetuximab soravtansine improves survival in platinum-resistant ovarian cancer

Treatment with mirvetuximab soravtansine, an antibody-drug conjugate (ADC) targeting folate receptor-alpha (FRα), led to significantly better survival outcomes in women with platinum-resistant ovarian cancer (PROC) compared with the investigator’s choice of chemotherapy, according to the MIRASOL trial presented at ASCO 2023.

Intravenous lacosamide for seizures well tolerated in children, infants

Treating seizures with intravenous lacosamide appears to be safe and is associated with low rates of adverse events among critically ill children and neonates, as reported in a study.

Platelet-rich fibrin matrix shows promise for trophic ulcers

Platelet-rich fibrin matrix (PRFM) compares favourably with platelet-rich plasma (PRP) in the treatment of chronic trophic ulcer associated with leprosy, as shown in the results of an observer-blind, noninferiority randomized controlled trial.